This strong phenotype from Optn knockdown was surprising, as studies on human patients with OPTN mutations have not described any overt defects, besides the progression of the studied disease (ALS, glaucoma or Paget’s disease of bone). This evidence concerns the gene OPTN and bone Paget disease.